Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Frontiers in Bioscience (Landmark Edition)|October 5, 2023
TP53 Mutations in Esophageal Squamous Cell CarcinomaLeqi Zhong, Hongmu Li, Wuguang Chang, et al.Genes|November 24, 2022
Identification and Validation of UPF1 as a Novel Prognostic Biomarker in Renal Clear Cell CarcinomaChun Wu, Hongmu Li, Wuguang Chang, et al.BMC Medical Genomics|July 22, 2025
The prognostic significance and Immunomodulatory role of SCGB3A1 expression in stage I lung adenocarcinomaXin Zhang, ShiNing Li, Yujin Lv, et al.Lung Cancer (Amsterdam, Netherlands)|November 16, 2025
Impact of N1 lymph node burden on survival outcomes in non-skip pN2 non-small-cell lung cancerBin Luo, Shenhua Liang, Leqi Zhong, et al.Frontiers in Immunology|December 16, 2022
Development of a copper metabolism-related gene signature in lung adenocarcinomaWuguang Chang, Hongmu Li, Leqi Zhong, et al.American Journal of Cancer Research|July 15, 2024
The upregulation of TGM2 is associated with poor prognosis and the shaping of the inflammatory tumor microenvironment in lung squamous cell carcinomaWuguang Chang, Wuyou Gao, Die Liu, et al.Genes|December 23, 2022
Identification of an Amino Acid Metabolism-Related Gene Signature for Predicting Prognosis in Lung AdenocarcinomaWuguang Chang, Hongmu Li, Chun Wu, et al.Journal of Thoracic Disease|June 17, 2024
Establishment and validation of a clinicopathological prediction model for postoperative recurrence of stage IA lung adenocarcinomaXin Zhang, Jie Yang, Shining Li, et al.Human Cell|May 3, 2024
VBP1 promotes tumor proliferation as a part of the hypoxia-related signature in esophageal squamous cell carcinomaHuikai Miao, Wuyou Gao, Leqi Zhong, et al.Cellular Signalling|October 23, 2024
PYGB targeted by androgen receptor contributes to tumor progression and metabolic reprogramming in esophageal squamous carcinomaHuikai Miao, Chunmei Xu, Wuyou Gao, et al.Pageof 3